Drug interactions: Concerns and current approaches

IDrugs

Volumn 10, Issue 1, 2007, Pages 47-52

  Nassar, Alaa Eldin F ^a   Talaat, Rasmy E ^b   Tokuno, Hajime ^c  

^a Vion Pharmaceuticals Incorporated   (United States)

^b PFIZER INC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug drug interactions; Human cytochrome P450 (CYP) enzyme; In silico; In vitro; Transporter

Indexed keywords

ALCOHOL; AMITRIPTYLINE; ANTACID AGENT; ANTICONVULSIVE AGENT; CAFFEINE; CERIVASTATIN; CIPROFLOXACIN; CLONIDINE; CYCLOSPORIN; DIAZEPAM; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IBUPROFEN; IRINOTECAN; NATALIZUMAB; NITRATE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; RAPACURONIUM BROMIDE; RIFAMPICIN; ROFECOXIB; SILDENAFIL; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT; TYSABRIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALDECOXIB; VITAMIN; VITAMIN K GROUP; WARFARIN; CYTOCHROME P450;

BLEEDING; BRONCHOSPASM; CACAO; CANCER; CARDIOVASCULAR DISEASE; COFFEE; COLA; CONFERENCE PAPER; DEPRESSION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG INDUSTRY; DRUG MARKETING; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; DRUG SENSITIVITY; DYSMENORRHEA; ECONOMIC ASPECT; ETHNICITY; FOOD DRUG INTERACTION; GENETIC POLYMORPHISM; GOVERNMENT; GRAPEFRUIT; HEART INFARCTION; HUMAN; LEGAL ASPECT; LIVER INJURY; MULTIPLE SCLEROSIS; NONHUMAN; OSTEOARTHRITIS; PAIN; PHARMACOLOGICAL PARAMETERS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PUBLIC RELATIONS; RHABDOMYOLYSIS; SKIN DISEASE; STROKE; ANIMAL; ARTICLE; BEVERAGE; BIOSYNTHESIS; DRUG INTERACTION; ENZYME INDUCTION;

ANIMALS; BEVERAGES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; FOOD-DRUG INTERACTIONS; HUMANS;

EID: 33947325662     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)